Hisham Shiblaq
Net Worth

Last updated:

What is Hisham Shiblaq net worth?

The estimated net worth of Mr. Hisham Shiblaq is at least $6,650,905 as of 10 Jun 2024. He owns shares worth $2,210,380 as insider, has earned $3,540,065 from insider trading and has received compensation worth at least $900,460 in PROCEPT BioRobotics Corporation.

What is the salary of Hisham Shiblaq?

Mr. Hisham Shiblaq salary is $450,230 per year as Senior Vice President of Global Commercialization in PROCEPT BioRobotics Corporation.

How old is Hisham Shiblaq?

Mr. Hisham Shiblaq is 50 years old, born in 1975.

What stocks does Hisham Shiblaq currently own?

As insider, Mr. Hisham Shiblaq owns shares in one company:

Company Title Shares Price per share Total value
PROCEPT BioRobotics Corporation (PRCT) Senior Vice President of Global Commercialization 55,860 $39.57 $2,210,380

What does PROCEPT BioRobotics Corporation do?

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

PRCT logo
PRCT
PROCEPT BioRobotics Corporation
$39.57

Hisham Shiblaq insider trading

PROCEPT BioRobotics Corporation

Mr. Hisham Shiblaq has made 9 insider trades between 2023-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 26,046 units of PRCT stock on 10 Jun 2024. As of 10 Jun 2024 he still owns at least 55,860 units of PRCT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 26,046 $4.56 $118,770
Option
Common Stock 26,046 $4.56 $118,770
Sale
Common Stock 26,046 $68.25 $1,777,509
Sale
Common Stock 244 $48.83 $11,915
Sale
Common Stock 1,759 $46.67 $82,093
Sale
Common Stock 21,930 $35.23 $772,506
Sale
Common Stock 246 $31.84 $7,833
Sale
Common Stock 466 $39.75 $18,521
Sale
Common Stock 5,421 $40.47 $219,382
Sale
Common Stock 9,736 $39.76 $387,094
Sale
Common Stock 6,306 $41.74 $263,212

PROCEPT BioRobotics key executives

PROCEPT BioRobotics Corporation executives and other stock owners filed with the SEC: